The survival analysis verified that the high expression of hsa-miR-944 predicted good prognosis and long-time survival of BC patients (P < 0.05) (Fig. 5A), while the high expression of HNRNPC predicted shorter OS of BC patients (P < 0.001) (Fig. 5B). Here, HNRNPC is linked to breast cancer.